Literature DB >> 24514914

Paediatric rheumatic disease: Treatment of JIA in the biologic era: what are we waiting for?

Taunton R Southwood1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24514914     DOI： 10.1038/nrrheum.2014.14

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis.

Authors:  Sarah Ringold; Pamela F Weiss; Robert A Colbert; Esi Morgan DeWitt; Tzielan Lee; Karen Onel; Sampath Prahalad; Rayfel Schneider; Susan Shenoi; Richard K Vehe; Yukiko Kimura
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-07       Impact factor: 4.794

2.  Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Edward H Giannini; Steven J Spalding; Philip J Hashkes; Kathleen M O'Neil; Andrew S Zeft; Ilona S Szer; Sarah Ringold; Hermine I Brunner; Laura E Schanberg; Robert P Sundel; Diana Milojevic; Marilynn G Punaro; Peter Chira; Beth S Gottlieb; Gloria C Higgins; Norman T Ilowite; Yukiko Kimura; Stephanie Hamilton; Anne Johnson; Bin Huang; Daniel J Lovell
Journal:  Arthritis Rheum       Date:  2011-12-19

3.  Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Authors:  Pirjo Tynjälä; Paula Vähäsalo; Maarit Tarkiainen; Liisa Kröger; Kristiina Aalto; Merja Malin; Anne Putto-Laurila; Visa Honkanen; Pekka Lahdenne
Journal:  Ann Rheum Dis       Date:  2011-05-28       Impact factor: 19.103

4.  Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.

Authors:  D J Lovell; E H Giannini; A Reiff; G D Cawkwell; E D Silverman; J J Nocton; L D Stein; A Gedalia; N T Ilowite; C A Wallace; J Whitmore; B K Finck
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

Review 5.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

6.  Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis.

Authors:  Vera Papsdorf; Gerd Horneff
Journal:  Rheumatology (Oxford)       Date:  2011-01       Impact factor: 7.580

7.  Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.

Authors:  Sarah Ringold; Timothy Beukelman; Peter A Nigrovic; Yukiko Kimura
Journal:  J Rheumatol       Date:  2013-04-15       Impact factor: 4.666

8.  Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.

Authors:  Nicolino Ruperto; Daniel J Lovell; Pierre Quartier; Eliana Paz; Nadina Rubio-Pérez; Clovis A Silva; Carlos Abud-Mendoza; Ruben Burgos-Vargas; Valeria Gerloni; Jose A Melo-Gomes; Claudia Saad-Magalhães; Flavio Sztajnbok; Claudia Goldenstein-Schainberg; Morton Scheinberg; Immaculada Calvo Penades; Michael Fischbach; Javier Orozco; Philip J Hashkes; Christine Hom; Lawrence Jung; Loredana Lepore; Sheila Oliveira; Carol A Wallace; Leonard H Sigal; Alan J Block; Allison Covucci; Alberto Martini; Edward H Giannini
Journal:  Lancet       Date:  2008-07-14       Impact factor: 79.321

9.  Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

Authors:  Daniel J Lovell; Nicolino Ruperto; Steven Goodman; Andreas Reiff; Lawrence Jung; Katerina Jarosova; Dana Nemcova; Richard Mouy; Christy Sandborg; John Bohnsack; Dirk Elewaut; Ivan Foeldvari; Valeria Gerloni; Jozef Rovensky; Kirsten Minden; Richard K Vehe; L Wagner Weiner; Gerd Horneff; Hans-Iko Huppertz; Nancy Y Olson; John R Medich; Roberto Carcereri-De-Prati; Melissa J McIlraith; Edward H Giannini; Alberto Martini
Journal:  N Engl J Med       Date:  2008-08-21       Impact factor: 91.245

10.  Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.

Authors:  Anne Hinks; Joanna Cobb; Miranda C Marion; Sampath Prahalad; Marc Sudman; John Bowes; Paul Martin; Mary E Comeau; Satria Sajuthi; Robert Andrews; Milton Brown; Wei-Min Chen; Patrick Concannon; Panos Deloukas; Sarah Edkins; Stephen Eyre; Patrick M Gaffney; Stephen L Guthery; Joel M Guthridge; Sarah E Hunt; Judith A James; Mehdi Keddache; Kathy L Moser; Peter A Nigrovic; Suna Onengut-Gumuscu; Mitchell L Onslow; Carlos D Rosé; Stephen S Rich; Kathryn J A Steel; Edward K Wakeland; Carol A Wallace; Lucy R Wedderburn; Patricia Woo; John F Bohnsack; Johannes Peter Haas; David N Glass; Carl D Langefeld; Wendy Thomson; Susan D Thompson
Journal:  Nat Genet       Date:  2013-04-21       Impact factor: 38.330
  10 in total
  3 in total

1.  Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis.

Authors:  Bin Huang; Tingting Qiu; Chen Chen; Yin Zhang; Michael Seid; Dan Lovell; Hermine I Brunner; Esi M Morgan
Journal:  RMD Open       Date:  2020-01

2.  Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.

Authors:  Rebecca Davies; Taunton R Southwood; Lianne Kearsley-Fleet; Mark Lunt; Kimme L Hyrich
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

3.  Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis.

Authors:  Mario Abinun; Jonathan P Lane; Mark Wood; Mark Friswell; Terence J Flood; Helen E Foster
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.